img

Global and India Meropenem for Injection Market Report & Forecast 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global and India Meropenem for Injection Market Report & Forecast 2024-2034

Market Analysis and InsightsGlobal and India Meropenem for Injection Market
This report focuses on global and India Meropenem for Injection market, also covers the segmentation data of other regions in regional level and county level.
The global Meropenem for Injection revenue was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period (2024-2034).
In India the Meropenem for Injection revenue is expected to grow from US$ million in 2024 to US$ million by 2034, at a CAGR of % during the forecast period (2024-2034).
The global key players of Meropenem for Injection include Sumitomo Dainippon Pharma Co.,Ltd., Joincare Pharmaceutical, Zhejiang Hisun, CSPC, Pfizer, Haikou Pharmaceutical Factory, PKU Healthcare, Shanghai Xinya Pharmaceutical and Shandong Luoxin Parmaceutical Group, etc. The global five biggest players hold a share of % in 2024.
Global Meropenem for Injection Scope and Market Size
Meropenem for Injection market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Meropenem for Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2034.
For India market, this report focuses on the Meropenem for Injection market size by players, by Type and by Application, for the period 2018-2034. The key players include the global and local players, which play important roles in India.



By Company


Sumitomo Dainippon Pharma Co.,Ltd.
Joincare Pharmaceutical
Zhejiang Hisun
CSPC
Pfizer
Haikou Pharmaceutical Factory
PKU Healthcare
Shanghai Xinya Pharmaceutical
Shandong Luoxin Parmaceutical Group
Shenghuaxi
North China Pharmaceutical Group
Mylan
Amneal Pharmaceuticals
Auromedics Pharmaceuticals
BBraun
Fresenius Kabi
Sandoz
Bionova Scientific
Macleods Pharmaceuticals
Segment by Type
0.25g
0.5g
1g

Segment by Application


Hospitals
Clinics
Other
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Meropenem for Injection definition, global sales (volume and revenue), India market size, India percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Meropenem for Injection companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Revenue and volume of Meropenem for Injection in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6Americas by type, by application and by country, sales, and revenue for each segment.
Chapter 7EMEA by type, by application and by region, sales, and revenue for each segment.
Chapter 8China by type, by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Meropenem for Injection sales, revenue, gross margin, and recent development, etc.
Chapter 11Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12Research findings and conclusion

Table of Content

1 Study Coverage
1.1 Meropenem for Injection Product Introduction
1.2 Global Meropenem for Injection Outlook 2018 VS 2024 VS 2034
1.2.1 Global Meropenem for Injection Sales in US$ Million for the Year 2018-2034
1.2.2 Global Meropenem for Injection Sales in Volume for the Year 2018-2034
1.3 India Meropenem for Injection Outlook 2018 VS 2024 VS 2034
1.3.1 India Meropenem for Injection Sales in US$ Million for the Year 2018-2034
1.3.2 India Meropenem for Injection Sales in Volume for the Year 2018-2034
1.4 Meropenem for Injection Market Size, India VS Global, 2018 VS 2024 VS 2034
1.4.1 The Market Share of India Meropenem for Injection in Global, 2018 VS 2024 VS 2034
1.4.2 The Growth Rate of Meropenem for Injection Market Size, India VS Global, 2018 VS 2024 VS 2034
1.5 Meropenem for Injection Market Dynamics
1.5.1 Meropenem for Injection Industry Trends
1.5.2 Meropenem for Injection Market Drivers
1.5.3 Meropenem for Injection Market Challenges
1.5.4 Meropenem for Injection Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 Meropenem for Injection by Type
2.1 Meropenem for Injection Market Segment by Type
2.1.1 0.25g
2.1.2 0.5g
2.1.3 1g
2.2 Global Meropenem for Injection Market Size by Type
2.2.1 Global Meropenem for Injection Sales in Value, by Type (2018, 2024 & 2034)
2.2.2 Global Meropenem for Injection Sales in Volume, by Type (2018, 2024 & 2034)
2.2.3 Global Meropenem for Injection Average Selling Price (ASP) by Type (2018, 2024 & 2034)
2.3 India Meropenem for Injection Market Size by Type
2.3.1 India Meropenem for Injection Sales in Value, by Type (2018, 2024 & 2034)
2.3.2 India Meropenem for Injection Sales in Volume, by Type (2018, 2024 & 2034)
2.3.3 India Meropenem for Injection Average Selling Price (ASP) by Type (2018, 2024 & 2034)
3 Meropenem for Injection by Application
3.1 Meropenem for Injection Market Segment by Application
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Other
3.2 Global Meropenem for Injection Market Size by Application
3.2.1 Global Meropenem for Injection Sales in Value, by Application (2018, 2024 & 2034)
3.2.2 Global Meropenem for Injection Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 Global Meropenem for Injection Average Selling Price (ASP) by Application (2018, 2024 & 2034)
3.3 India Meropenem for Injection Market Size by Application
3.3.1 India Meropenem for Injection Sales in Value, by Application (2018, 2024 & 2034)
3.3.2 India Meropenem for Injection Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 India Meropenem for Injection Average Selling Price (ASP) by Application (2018, 2024 & 2034)
4 Global Meropenem for Injection Competitor Landscape by Company
4.1 Global Meropenem for Injection Market Size by Company
4.1.1 Global Key Manufacturers of Meropenem for Injection, Ranked by Revenue (2024)
4.1.2 Global Meropenem for Injection Revenue by Manufacturer (2018-2023)
4.1.3 Global Meropenem for Injection Sales by Manufacturer (2018-2023)
4.1.4 Global Meropenem for Injection Price by Manufacturer (2018-2023)
4.2 Global Meropenem for Injection Concentration Ratio (CR)
4.2.1 Meropenem for Injection Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Meropenem for Injection in 2024
4.2.3 Global Meropenem for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Meropenem for Injection, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Meropenem for Injection, Product Offered and Application
4.5 Global Key Manufacturers of Meropenem for Injection, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 India Meropenem for Injection Market Size by Company
4.7.1 Key Players of Meropenem for Injection in India, Ranked by Revenue (2024)
4.7.2 India Meropenem for Injection Revenue by Players (2018-2023)
4.7.3 India Meropenem for Injection Sales by Players (2018-2023)
5 Global Meropenem for Injection Market Size by Region
5.1 Global Meropenem for Injection Market Size by Region: 2018 VS 2024 VS 2034
5.2 Global Meropenem for Injection Market Size in Volume by Region (2018-2034)
5.2.1 Global Meropenem for Injection Sales in Volume by Region: 2018-2023
5.2.2 Global Meropenem for Injection Sales in Volume Forecast by Region (2024-2034)
5.3 Global Meropenem for Injection Market Size in Value by Region (2018-2034)
5.3.1 Global Meropenem for Injection Sales in Value by Region: 2018-2023
5.3.2 Global Meropenem for Injection Sales in Value by Region: 2024-2034
6 Americas
6.1 Americas Meropenem for Injection Market Size YoY Growth 2018-2034
6.2 Americas Meropenem for Injection Sales in Volume, by Type (2018, 2024 & 2034)
6.3 Americas Meropenem for Injection Sales in Volume, by Application (2018, 2024 & 2034)
6.4 Americas Meropenem for Injection Market Facts & Figures by Country (2018, 2024 & 2034)
6.4.1 Americas Meropenem for Injection Sales in Value by Country (2018, 2024 & 2034)
6.4.2 Americas Meropenem for Injection Sales in Volume by Country (2018, 2024 & 2034)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Meropenem for Injection Market Size YoY Growth 2018-2034
7.2 EMEA Meropenem for Injection Sales in Volume, by Type (2018, 2024 & 2034)
7.3 EMEA Meropenem for Injection Sales in Volume, by Application (2018, 2024 & 2034)
7.4 EMEA Meropenem for Injection Market Facts & Figures by Country (2018, 2024 & 2034)
7.4.1 EMEA Meropenem for Injection Sales in Value by Country (2018, 2024 & 2034)
7.4.2 EMEA Meropenem for Injection Sales in Volume by Country (2018, 2024 & 2034)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Meropenem for Injection Market Size YoY Growth 2018-2034
8.2 China Meropenem for Injection Sales in Volume, by Type (2018, 2024 & 2034)
8.3 China Meropenem for Injection Sales in Volume, by Application (2018, 2024 & 2034)
9 APAC
9.1 APAC Meropenem for Injection Market Size YoY Growth 2018-2034
9.2 APAC Meropenem for Injection Sales in Volume, by Type (2018, 2024 & 2034)
9.3 APAC Meropenem for Injection Sales in Volume, by Application (2018, 2024 & 2034)
9.4 APAC Meropenem for Injection Market Facts & Figures by Region (2018, 2024 & 2034)
9.4.1 APAC Meropenem for Injection Sales in Value by Region (2018, 2024 & 2034)
9.4.2 APAC Meropenem for Injection Sales in Volume by Region (2018, 2024 & 2034)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Sumitomo Dainippon Pharma Co.,Ltd.
10.1.1 Sumitomo Dainippon Pharma Co.,Ltd. Company Information
10.1.2 Sumitomo Dainippon Pharma Co.,Ltd. Description and Business Overview
10.1.3 Sumitomo Dainippon Pharma Co.,Ltd. Meropenem for Injection Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Sumitomo Dainippon Pharma Co.,Ltd. Meropenem for Injection Products Offered
10.1.5 Sumitomo Dainippon Pharma Co.,Ltd. Recent Development
10.2 Joincare Pharmaceutical
10.2.1 Joincare Pharmaceutical Company Information
10.2.2 Joincare Pharmaceutical Description and Business Overview
10.2.3 Joincare Pharmaceutical Meropenem for Injection Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Joincare Pharmaceutical Meropenem for Injection Products Offered
10.2.5 Joincare Pharmaceutical Recent Development
10.3 Zhejiang Hisun
10.3.1 Zhejiang Hisun Company Information
10.3.2 Zhejiang Hisun Description and Business Overview
10.3.3 Zhejiang Hisun Meropenem for Injection Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Zhejiang Hisun Meropenem for Injection Products Offered
10.3.5 Zhejiang Hisun Recent Development
10.4 CSPC
10.4.1 CSPC Company Information
10.4.2 CSPC Description and Business Overview
10.4.3 CSPC Meropenem for Injection Sales, Revenue and Gross Margin (2018-2023)
10.4.4 CSPC Meropenem for Injection Products Offered
10.4.5 CSPC Recent Development
10.5 Pfizer
10.5.1 Pfizer Company Information
10.5.2 Pfizer Description and Business Overview
10.5.3 Pfizer Meropenem for Injection Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Pfizer Meropenem for Injection Products Offered
10.5.5 Pfizer Recent Development
10.6 Haikou Pharmaceutical Factory
10.6.1 Haikou Pharmaceutical Factory Company Information
10.6.2 Haikou Pharmaceutical Factory Description and Business Overview
10.6.3 Haikou Pharmaceutical Factory Meropenem for Injection Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Haikou Pharmaceutical Factory Meropenem for Injection Products Offered
10.6.5 Haikou Pharmaceutical Factory Recent Development
10.7 PKU Healthcare
10.7.1 PKU Healthcare Company Information
10.7.2 PKU Healthcare Description and Business Overview
10.7.3 PKU Healthcare Meropenem for Injection Sales, Revenue and Gross Margin (2018-2023)
10.7.4 PKU Healthcare Meropenem for Injection Products Offered
10.7.5 PKU Healthcare Recent Development
10.8 Shanghai Xinya Pharmaceutical
10.8.1 Shanghai Xinya Pharmaceutical Company Information
10.8.2 Shanghai Xinya Pharmaceutical Description and Business Overview
10.8.3 Shanghai Xinya Pharmaceutical Meropenem for Injection Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Shanghai Xinya Pharmaceutical Meropenem for Injection Products Offered
10.8.5 Shanghai Xinya Pharmaceutical Recent Development
10.9 Shandong Luoxin Parmaceutical Group
10.9.1 Shandong Luoxin Parmaceutical Group Company Information
10.9.2 Shandong Luoxin Parmaceutical Group Description and Business Overview
10.9.3 Shandong Luoxin Parmaceutical Group Meropenem for Injection Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Shandong Luoxin Parmaceutical Group Meropenem for Injection Products Offered
10.9.5 Shandong Luoxin Parmaceutical Group Recent Development
10.10 Shenghuaxi
10.10.1 Shenghuaxi Company Information
10.10.2 Shenghuaxi Description and Business Overview
10.10.3 Shenghuaxi Meropenem for Injection Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Shenghuaxi Meropenem for Injection Products Offered
10.10.5 Shenghuaxi Recent Development
10.11 North China Pharmaceutical Group
10.11.1 North China Pharmaceutical Group Company Information
10.11.2 North China Pharmaceutical Group Description and Business Overview
10.11.3 North China Pharmaceutical Group Meropenem for Injection Sales, Revenue and Gross Margin (2018-2023)
10.11.4 North China Pharmaceutical Group Meropenem for Injection Products Offered
10.11.5 North China Pharmaceutical Group Recent Development
10.12 Mylan
10.12.1 Mylan Company Information
10.12.2 Mylan Description and Business Overview
10.12.3 Mylan Meropenem for Injection Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Mylan Meropenem for Injection Products Offered
10.12.5 Mylan Recent Development
10.13 Amneal Pharmaceuticals
10.13.1 Amneal Pharmaceuticals Company Information
10.13.2 Amneal Pharmaceuticals Description and Business Overview
10.13.3 Amneal Pharmaceuticals Meropenem for Injection Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Amneal Pharmaceuticals Meropenem for Injection Products Offered
10.13.5 Amneal Pharmaceuticals Recent Development
10.14 Auromedics Pharmaceuticals
10.14.1 Auromedics Pharmaceuticals Company Information
10.14.2 Auromedics Pharmaceuticals Description and Business Overview
10.14.3 Auromedics Pharmaceuticals Meropenem for Injection Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Auromedics Pharmaceuticals Meropenem for Injection Products Offered
10.14.5 Auromedics Pharmaceuticals Recent Development
10.15 BBraun
10.15.1 BBraun Company Information
10.15.2 BBraun Description and Business Overview
10.15.3 BBraun Meropenem for Injection Sales, Revenue and Gross Margin (2018-2023)
10.15.4 BBraun Meropenem for Injection Products Offered
10.15.5 BBraun Recent Development
10.16 Fresenius Kabi
10.16.1 Fresenius Kabi Company Information
10.16.2 Fresenius Kabi Description and Business Overview
10.16.3 Fresenius Kabi Meropenem for Injection Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Fresenius Kabi Meropenem for Injection Products Offered
10.16.5 Fresenius Kabi Recent Development
10.17 Sandoz
10.17.1 Sandoz Company Information
10.17.2 Sandoz Description and Business Overview
10.17.3 Sandoz Meropenem for Injection Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Sandoz Meropenem for Injection Products Offered
10.17.5 Sandoz Recent Development
10.18 Bionova Scientific
10.18.1 Bionova Scientific Company Information
10.18.2 Bionova Scientific Description and Business Overview
10.18.3 Bionova Scientific Meropenem for Injection Sales, Revenue and Gross Margin (2018-2023)
10.18.4 Bionova Scientific Meropenem for Injection Products Offered
10.18.5 Bionova Scientific Recent Development
10.19 Macleods Pharmaceuticals
10.19.1 Macleods Pharmaceuticals Company Information
10.19.2 Macleods Pharmaceuticals Description and Business Overview
10.19.3 Macleods Pharmaceuticals Meropenem for Injection Sales, Revenue and Gross Margin (2018-2023)
10.19.4 Macleods Pharmaceuticals Meropenem for Injection Products Offered
10.19.5 Macleods Pharmaceuticals Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Meropenem for Injection Industry Chain Analysis
11.2 Meropenem for Injection Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Meropenem for Injection Production Mode & Process
11.4 Meropenem for Injection Sales and Marketing
11.4.1 Meropenem for Injection Sales Channels
11.4.2 Meropenem for Injection Distributors
11.5 Meropenem for Injection Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Figure

List of Tables
Table 1. Meropenem for Injection CAGR in Value, India VS Global, 2018 VS 2024 VS 2034
Table 2. Meropenem for Injection Market Trends
Table 3. Meropenem for Injection Market Drivers
Table 4. Meropenem for Injection Market Challenges
Table 5. Meropenem for Injection Market Restraints
Table 6. Global Meropenem for Injection Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. India Meropenem for Injection Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Meropenem for Injection Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. India Meropenem for Injection Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Key Manufacturers of Meropenem for Injection, Ranked by Revenue (2024) & (US$ Million)
Table 11. Global Meropenem for Injection Revenue by Manufacturer, (US$ Million), 2018-2023
Table 12. Global Meropenem for Injection Revenue Share by Manufacturer, 2018-2023
Table 13. Global Meropenem for Injection Sales by Manufacturer, (K Units), 2018-2023
Table 14. Global Meropenem for Injection Sales Share by Manufacturer, 2018-2023
Table 15. Global Meropenem for Injection Price by Manufacturer (2018-2023) & (US$/Unit)
Table 16. Global Meropenem for Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Meropenem for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meropenem for Injection as of 2024)
Table 18. Global Key Manufacturers of Meropenem for Injection, Manufacturing Base Distribution and Headquarters
Table 19. Global Key Manufacturers of Meropenem for Injection, Product Offered and Application
Table 20. Global Key Manufacturers of Meropenem for Injection, Date of Enter into This Industry
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Key Players of Meropenem for Injection in India, Ranked by Revenue (2024) & (US$ million)
Table 23. India Meropenem for Injection Revenue by Players, (US$ Million), (2018-2023)
Table 24. India Meropenem for Injection Revenue Share by Players, (2018-2023)
Table 25. India Meropenem for Injection Sales by Players, (K Units), (2018-2023)
Table 26. India Meropenem for Injection Sales Share by Players, (2018-2023)
Table 27. Global Meropenem for Injection Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 28. Global Meropenem for Injection Sales in Volume by Region (2018-2023) & (K Units)
Table 29. Global Meropenem for Injection Sales in Volume Forecast by Region (2024-2034) & (K Units)
Table 30. Global Meropenem for Injection Sales in Value by Region (2018-2023) & (US$ Million)
Table 31. Global Meropenem for Injection Sales in Value Forecast by Region (2024-2034) & (US$ Million)
Table 32. Americas Meropenem for Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 33. Americas Meropenem for Injection Sales in Value by Country (2018-2023) & (US$ Million)
Table 34. Americas Meropenem for Injection Sales in Value by Country (2024-2034) & (US$ Million)
Table 35. Americas Meropenem for Injection Sales in Volume by Country (2018-2023) & (K Units)
Table 36. Americas Meropenem for Injection Sales in Volume by Country (2024-2034) & (K Units)
Table 37. EMEA Meropenem for Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 38. EMEA Meropenem for Injection Sales in Value by Country (2018-2023) & (US$ Million)
Table 39. EMEA Meropenem for Injection Sales in Value by Country (2024-2034) & (US$ Million)
Table 40. EMEA Meropenem for Injection Sales in Volume by Country (2018-2023) & (K Units)
Table 41. EMEA Meropenem for Injection Sales in Volume by Country (2024-2034) & (K Units)
Table 42. APAC Meropenem for Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 43. APAC Meropenem for Injection Sales in Value by Country (2018-2023) & (US$ Million)
Table 44. APAC Meropenem for Injection Sales in Value by Country (2024-2034) & (US$ Million)
Table 45. APAC Meropenem for Injection Sales in Volume by Country (2018-2023) & (K Units)
Table 46. APAC Meropenem for Injection Sales in Volume by Country (2024-2034) & (K Units)
Table 47. Sumitomo Dainippon Pharma Co.,Ltd. Company Information
Table 48. Sumitomo Dainippon Pharma Co.,Ltd. Description and Business Overview
Table 49. Sumitomo Dainippon Pharma Co.,Ltd. Meropenem for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 50. Sumitomo Dainippon Pharma Co.,Ltd. Meropenem for Injection Product
Table 51. Sumitomo Dainippon Pharma Co.,Ltd. Recent Development
Table 52. Joincare Pharmaceutical Company Information
Table 53. Joincare Pharmaceutical Description and Business Overview
Table 54. Joincare Pharmaceutical Meropenem for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 55. Joincare Pharmaceutical Meropenem for Injection Product
Table 56. Joincare Pharmaceutical Recent Development
Table 57. Zhejiang Hisun Company Information
Table 58. Zhejiang Hisun Description and Business Overview
Table 59. Zhejiang Hisun Meropenem for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 60. Zhejiang Hisun Meropenem for Injection Product
Table 61. Zhejiang Hisun Recent Development
Table 62. CSPC Company Information
Table 63. CSPC Description and Business Overview
Table 64. CSPC Meropenem for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 65. CSPC Meropenem for Injection Product
Table 66. CSPC Recent Development
Table 67. Pfizer Company Information
Table 68. Pfizer Description and Business Overview
Table 69. Pfizer Meropenem for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 70. Pfizer Meropenem for Injection Product
Table 71. Pfizer Recent Development
Table 72. Haikou Pharmaceutical Factory Company Information
Table 73. Haikou Pharmaceutical Factory Description and Business Overview
Table 74. Haikou Pharmaceutical Factory Meropenem for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 75. Haikou Pharmaceutical Factory Meropenem for Injection Product
Table 76. Haikou Pharmaceutical Factory Recent Development
Table 77. PKU Healthcare Company Information
Table 78. PKU Healthcare Description and Business Overview
Table 79. PKU Healthcare Meropenem for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 80. PKU Healthcare Meropenem for Injection Product
Table 81. PKU Healthcare Recent Development
Table 82. Shanghai Xinya Pharmaceutical Company Information
Table 83. Shanghai Xinya Pharmaceutical Description and Business Overview
Table 84. Shanghai Xinya Pharmaceutical Meropenem for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 85. Shanghai Xinya Pharmaceutical Meropenem for Injection Product
Table 86. Shanghai Xinya Pharmaceutical Recent Development
Table 87. Shandong Luoxin Parmaceutical Group Company Information
Table 88. Shandong Luoxin Parmaceutical Group Description and Business Overview
Table 89. Shandong Luoxin Parmaceutical Group Meropenem for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 90. Shandong Luoxin Parmaceutical Group Meropenem for Injection Product
Table 91. Shandong Luoxin Parmaceutical Group Recent Development
Table 92. Shenghuaxi Company Information
Table 93. Shenghuaxi Description and Business Overview
Table 94. Shenghuaxi Meropenem for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 95. Shenghuaxi Meropenem for Injection Product
Table 96. Shenghuaxi Recent Development
Table 97. North China Pharmaceutical Group Company Information
Table 98. North China Pharmaceutical Group Description and Business Overview
Table 99. North China Pharmaceutical Group Meropenem for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 100. North China Pharmaceutical Group Meropenem for Injection Product
Table 101. North China Pharmaceutical Group Recent Development
Table 102. Mylan Company Information
Table 103. Mylan Description and Business Overview
Table 104. Mylan Meropenem for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 105. Mylan Meropenem for Injection Product
Table 106. Mylan Recent Development
Table 107. Amneal Pharmaceuticals Company Information
Table 108. Amneal Pharmaceuticals Description and Business Overview
Table 109. Amneal Pharmaceuticals Meropenem for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 110. Amneal Pharmaceuticals Meropenem for Injection Product
Table 111. Amneal Pharmaceuticals Recent Development
Table 112. Auromedics Pharmaceuticals Company Information
Table 113. Auromedics Pharmaceuticals Description and Business Overview
Table 114. Auromedics Pharmaceuticals Meropenem for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 115. Auromedics Pharmaceuticals Meropenem for Injection Product
Table 116. Auromedics Pharmaceuticals Recent Development
Table 117. BBraun Company Information
Table 118. BBraun Description and Business Overview
Table 119. BBraun Meropenem for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 120. BBraun Meropenem for Injection Product
Table 121. BBraun Recent Development
Table 122. Fresenius Kabi Company Information
Table 123. Fresenius Kabi Description and Business Overview
Table 124. Fresenius Kabi Meropenem for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 125. Fresenius Kabi Meropenem for Injection Product
Table 126. Fresenius Kabi Recent Development
Table 127. Sandoz Company Information
Table 128. Sandoz Description and Business Overview
Table 129. Sandoz Meropenem for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 130. Sandoz Meropenem for Injection Product
Table 131. Sandoz Recent Development
Table 132. Bionova Scientific Company Information
Table 133. Bionova Scientific Description and Business Overview
Table 134. Bionova Scientific Meropenem for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 135. Bionova Scientific Meropenem for Injection Product
Table 136. Bionova Scientific Recent Development
Table 137. Macleods Pharmaceuticals Company Information
Table 138. Macleods Pharmaceuticals Description and Business Overview
Table 139. Macleods Pharmaceuticals Meropenem for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 140. Macleods Pharmaceuticals Meropenem for Injection Product
Table 141. Macleods Pharmaceuticals Recent Development
Table 142. Key Raw Materials Lists
Table 143. Raw Materials Key Suppliers Lists
Table 144. Meropenem for Injection Customers List
Table 145. Meropenem for Injection Distributors List
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Meropenem for Injection Product Picture
Figure 2. Global Meropenem for Injection Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 3. Global Meropenem for Injection Market Size 2018-2034 (US$ Million)
Figure 4. Global Meropenem for Injection Sales 2018-2034 (K Units)
Figure 5. India Meropenem for Injection Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 6. India Meropenem for Injection Market Size 2018-2034 (US$ Million)
Figure 7. India Meropenem for Injection Sales 2018-2034 (K Units)
Figure 8. India Meropenem for Injection Market Share in Global, in Value (US$ Million) 2018-2034
Figure 9. India Meropenem for Injection Market Share in Global, in Volume (K Units) 2018-2034
Figure 10. Meropenem for Injection Report Years Considered
Figure 11. Product Picture of 0.25g
Figure 12. Product Picture of 0.5g
Figure 13. Product Picture of 1g
Figure 14. Global Meropenem for Injection Market Share by Type in 2024 & 2034
Figure 15. Global Meropenem for Injection Sales in Value by Type (2018-2034) & (US$ Million)
Figure 16. Global Meropenem for Injection Sales Market Share in Value by Type (2018-2034)
Figure 17. Global Meropenem for Injection Sales by Type (2018-2034) & (K Units)
Figure 18. Global Meropenem for Injection Sales Market Share in Volume by Type (2018-2034)
Figure 19. Global Meropenem for Injection Price by Type (2018-2034) & (US$/Unit)
Figure 20. India Meropenem for Injection Market Share by Type in 2024 & 2034
Figure 21. India Meropenem for Injection Sales in Value by Type (2018-2034) & (US$ Million)
Figure 22. India Meropenem for Injection Sales Market Share in Value by Type (2018-2034)
Figure 23. India Meropenem for Injection Sales by Type (2018-2034) & (K Units)
Figure 24. India Meropenem for Injection Sales Market Share in Volume by Type (2018-2034)
Figure 25. India Meropenem for Injection Price by Type (2018-2034) & (US$/Unit)
Figure 26. Product Picture of Hospitals
Figure 27. Product Picture of Clinics
Figure 28. Product Picture of Other
Figure 29. Global Meropenem for Injection Market Share by Application in 2024 & 2034
Figure 30. Global Meropenem for Injection Sales in Value by Application (2018-2034) & (US$ Million)
Figure 31. Global Meropenem for Injection Sales Market Share in Value by Application (2018-2034)
Figure 32. Global Meropenem for Injection Sales by Application (2018-2034) & (K Units)
Figure 33. Global Meropenem for Injection Sales Market Share in Volume by Application (2018-2034)
Figure 34. Global Meropenem for Injection Price by Application (2018-2034) & (US$/Unit)
Figure 35. India Meropenem for Injection Market Share by Application in 2024 & 2034
Figure 36. India Meropenem for Injection Sales in Value by Application (2018-2034) & (US$ Million)
Figure 37. India Meropenem for Injection Sales Market Share in Value by Application (2018-2034)
Figure 38. India Meropenem for Injection Sales by Application (2018-2034) & (K Units)
Figure 39. India Meropenem for Injection Sales Market Share in Volume by Application (2018-2034)
Figure 40. India Meropenem for Injection Price by Application (2018-2034) & (US$/Unit)
Figure 41. Americas Meropenem for Injection Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 42. Americas Meropenem for Injection Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 43. Americas Meropenem for Injection Sales by Type (2018-2034) & (K Units)
Figure 44. Americas Meropenem for Injection Sales Market Share in Volume by Type (2018-2034)
Figure 45. Americas Meropenem for Injection Sales by Application (2018-2034) & (K Units)
Figure 46. Americas Meropenem for Injection Sales Market Share in Volume by Application (2018-2034)
Figure 47. United States Meropenem for Injection Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 48. Canada Meropenem for Injection Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 49. Mexico Meropenem for Injection Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 50. Brazil Meropenem for Injection Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 51. EMEA Meropenem for Injection Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 52. EMEA Meropenem for Injection Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 53. EMEA Meropenem for Injection Sales by Type (2018-2034) & (K Units)
Figure 54. EMEA Meropenem for Injection Sales Market Share in Volume by Type (2018-2034)
Figure 55. EMEA Meropenem for Injection Sales by Application (2018-2034) & (K Units)
Figure 56. EMEA Meropenem for Injection Sales Market Share in Volume by Application (2018-2034)
Figure 57. Europe Meropenem for Injection Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 58. Middle East Meropenem for Injection Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 59. Africa Meropenem for Injection Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 60. China Meropenem for Injection Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 61. China Meropenem for Injection Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 62. China Meropenem for Injection Sales by Type (2018-2034) & (K Units)
Figure 63. China Meropenem for Injection Sales Market Share in Volume by Type (2018-2034)
Figure 64. China Meropenem for Injection Sales by Application (2018-2034) & (K Units)
Figure 65. China Meropenem for Injection Sales Market Share in Volume by Application (2018-2034)
Figure 66. APAC Meropenem for Injection Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 67. APAC Meropenem for Injection Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 68. APAC Meropenem for Injection Sales by Type (2018-2034) & (K Units)
Figure 69. APAC Meropenem for Injection Sales Market Share in Volume by Type (2018-2034)
Figure 70. APAC Meropenem for Injection Sales by Application (2018-2034) & (K Units)
Figure 71. APAC Meropenem for Injection Sales Market Share in Volume by Application (2018-2034)
Figure 72. Japan Meropenem for Injection Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 73. South Korea Meropenem for Injection Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 74. China Taiwan Meropenem for Injection Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 75. Southeast Asia Meropenem for Injection Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 76. India Meropenem for Injection Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 77. Meropenem for Injection Value Chain
Figure 78. Meropenem for Injection Production Process
Figure 79. Channels of Distribution
Figure 80. Distributors Profiles
Figure 81. Bottom-up and Top-down Approaches for This Report
Figure 82. Data Triangulation
Figure 83. Key Executives Interviewed